Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Anti-PD-1 Immunotherapy-Induced Flare of a Known Underlying Relapsing Vasculitis Mimicking Recurrent Cancer.

Nabel CS, Severgnini M, Hung YP, Cunningham-Bussel A, Gjini E, Kleinsteuber K, Seymour LJ, Holland MK, Cunningham R, Felt KD, Vivero M, Rodig SJ, Massarotti EM, Rahma OE, Harshman LC.

Oncologist. 2019 May 14. pii: theoncologist.2018-0633. doi: 10.1634/theoncologist.2018-0633. [Epub ahead of print]

PMID:
31088979
2.

Mixed-effects association of single cells identifies an expanded effector CD4+ T cell subset in rheumatoid arthritis.

Fonseka CY, Rao DA, Teslovich NC, Korsunsky I, Hannes SK, Slowikowski K, Gurish MF, Donlin LT, Lederer JA, Weinblatt ME, Massarotti EM, Coblyn JS, Helfgott SM, Todd DJ, Bykerk VP, Karlson EW, Ermann J, Lee YC, Brenner MB, Raychaudhuri S.

Sci Transl Med. 2018 Oct 17;10(463). pii: eaaq0305. doi: 10.1126/scitranslmed.aaq0305.

3.

Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis.

Rao DA, Gurish MF, Marshall JL, Slowikowski K, Fonseka CY, Liu Y, Donlin LT, Henderson LA, Wei K, Mizoguchi F, Teslovich NC, Weinblatt ME, Massarotti EM, Coblyn JS, Helfgott SM, Lee YC, Todd DJ, Bykerk VP, Goodman SM, Pernis AB, Ivashkiv LB, Karlson EW, Nigrovic PA, Filer A, Buckley CD, Lederer JA, Raychaudhuri S, Brenner MB.

Nature. 2017 Feb 1;542(7639):110-114. doi: 10.1038/nature20810.

4.

Editorial: Interferon-Targeted Therapy for Systemic Lupus Erythematosus: Are the Trials on Target?

Massarotti EM, Allore HG, Costenbader K.

Arthritis Rheumatol. 2017 Feb;69(2):245-248. doi: 10.1002/art.39985. No abstract available.

5.

Testing Limits.

Massarotti EM, Sax PE, Compton L, Levy BD, Loscalzo J.

N Engl J Med. 2016 Oct 6;375(14):1383-1388. No abstract available.

PMID:
27705260
6.

Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation with clinical measures of disease activity.

Pope J, Bingham CO 3rd, Fleischmann RM, Dougados M, Massarotti EM, Wollenhaupt J, Duncan B, Coteur G, Weinblatt ME.

Arthritis Res Ther. 2015 Nov 27;17:343. doi: 10.1186/s13075-015-0849-1.

7.

Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus Erythematosus.

Aranow C, Kamen DL, Dall'Era M, Massarotti EM, Mackay MC, Koumpouras F, Coca A, Chatham WW, Clowse ME, Criscione-Schreiber LG, Callahan S, Goldmuntz EA, Keyes-Elstein L, Oswald M, Gregersen PK, Diamond B.

Arthritis Rheumatol. 2015 Jul;67(7):1848-57. doi: 10.1002/art.39108.

8.

Development of SLE among "potential SLE" patients seen in consultation: long-term follow-up.

Al Daabil M, Massarotti EM, Fine A, Tsao H, Ho P, Schur PH, Bermas BL, Costenbader KH.

Int J Clin Pract. 2014 Dec;68(12):1508-13. doi: 10.1111/ijcp.12466. Epub 2014 May 23.

9.

The potential role of ‘non-rheumatic’ therapies in rheumatic disease.

Massarotti EM, Solomon DH.

Arthritis Res Ther. 2013;15(6):124.

10.

The new ACR/EULAR remission criteria: rationale for developing new criteria for remission.

Bykerk VP, Massarotti EM.

Rheumatology (Oxford). 2012 Dec;51 Suppl 6:vi16-20. doi: 10.1093/rheumatology/kes281. Review.

PMID:
23221582
11.

The new ACR/EULAR classification criteria for RA: how are the new criteria performing in the clinic?

Bykerk VP, Massarotti EM.

Rheumatology (Oxford). 2012 Dec;51 Suppl 6:vi10-5. doi: 10.1093/rheumatology/kes280. Review.

PMID:
23221581
12.

Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus.

Kalunian KC, Chatham WW, Massarotti EM, Reyes-Thomas J, Harris C, Furie RA, Chitkara P, Putterman C, Gross RL, Somers EC, Kirou KA, Ramsey-Goldman R, Hsieh C, Buyon JP, Dervieux T, Weinstein A.

Arthritis Rheum. 2012 Dec;64(12):4040-7. doi: 10.1002/art.34669.

13.

Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study.

Weinblatt ME, Fleischmann R, Huizinga TW, Emery P, Pope J, Massarotti EM, van Vollenhoven RF, Wollenhaupt J, Bingham CO 3rd, Duncan B, Goel N, Davies OR, Dougados M.

Rheumatology (Oxford). 2012 Dec;51(12):2204-14. doi: 10.1093/rheumatology/kes150. Epub 2012 Aug 25.

PMID:
22923753
14.

Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals.

Mercer E, Rekedal L, Garg R, Lu B, Massarotti EM, Solomon DH.

Arthritis Res Ther. 2012 Jun 7;14(3):R135. doi: 10.1186/ar3868.

15.

Panniculitis associated with dermatomyositis and recurrent ovarian cancer.

Girouard SD, Velez NF, Penson RT, Massarotti EM, Vleugels RA.

Arch Dermatol. 2012 Jun;148(6):740-4. doi: 10.1001/archdermatol.2012.288.

PMID:
22431715
16.

To what extent can preventive treatments prevent damage from systemic lupus erythematosus?

Massarotti EM, Schur PH.

Curr Rheumatol Rep. 2011 Aug;13(4):317-23. doi: 10.1007/s11926-011-0188-4. Review.

PMID:
21611806
17.

A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis.

Boilard E, Lai Y, Larabee K, Balestrieri B, Ghomashchi F, Fujioka D, Gobezie R, Coblyn JS, Weinblatt ME, Massarotti EM, Thornhill TS, Divangahi M, Remold H, Lambeau G, Gelb MH, Arm JP, Lee DM.

EMBO Mol Med. 2010 May;2(5):172-87. doi: 10.1002/emmm.201000072.

18.

Identification and validation of lupus nephritis cases using administrative data.

Chibnik LB, Massarotti EM, Costenbader KH.

Lupus. 2010 May;19(6):741-3. doi: 10.1177/0961203309356289. Epub 2010 Feb 23.

19.

Platelets amplify inflammation in arthritis via collagen-dependent microparticle production.

Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, Massarotti EM, Remold-O'Donnell E, Farndale RW, Ware J, Lee DM.

Science. 2010 Jan 29;327(5965):580-3. doi: 10.1126/science.1181928.

20.

FAST4WARD: implications for the clinician.

Massarotti EM.

Int J Clin Pract. 2009 Jul;63(7):986-8. doi: 10.1111/j.1742-1241.2009.02095.x. No abstract available.

PMID:
19570115
21.

Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists.

Asarch A, Gottlieb AB, Lee J, Masterpol KS, Scheinman PL, Stadecker MJ, Massarotti EM, Bush ML.

J Am Acad Dermatol. 2009 Jul;61(1):104-11. doi: 10.1016/j.jaad.2008.09.032. Review.

PMID:
19539844
22.

Clinical and patient-reported outcomes in clinical trials of abatacept in the treatment of rheumatoid arthritis.

Massarotti EM.

Clin Ther. 2008 Mar;30(3):429-42. doi: 10.1016/j.clinthera.2008.03.002. Review.

PMID:
18405783
23.

Effect of glutathione S-transferase polymorphisms and proximity to hazardous waste sites on time to systemic lupus erythematosus diagnosis: results from the Roxbury lupus project.

Karlson EW, Watts J, Signorovitch J, Bonetti M, Wright E, Cooper GS, McAlindon TE, Costenbader KH, Massarotti EM, Fitzgerald LM, Jajoo R, Husni ME, Fossel AH, Pankey H, Ding WZ, Knorr R, Condon S, Fraser PA.

Arthritis Rheum. 2007 Jan;56(1):244-54.

24.

High sensitivity, specificity and predictive value of the Connective Tissue Disease Screening Questionnaire among urban African-American women.

Karlson EW, Costenbader KH, McAlindon TE, Massarotti EM, Fitzgerald LM, Jajoo R, Husni E, Wright EA, Pankey H, Fraser PA.

Lupus. 2005;14(10):832-6.

PMID:
16304727
25.

The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status.

Lee AT, Li W, Liew A, Bombardier C, Weisman M, Massarotti EM, Kent J, Wolfe F, Begovich AB, Gregersen PK.

Genes Immun. 2005 Mar;6(2):129-33.

PMID:
15674368
26.

Lyme arthritis.

Massarotti EM.

Med Clin North Am. 2002 Mar;86(2):297-309. Review.

PMID:
11982303
27.

Medical aspects of rheumatoid arthritis. Diagnosis and treatment.

Massarotti EM.

Hand Clin. 1996 Aug;12(3):463-75. Review.

PMID:
8842713
28.

Anaerobic septic bursitis: case report and review.

Fischer PA, Kopp A, Massarotti EM.

Clin Infect Dis. 1996 May;22(5):879. Review. No abstract available.

PMID:
8722967
29.

Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy.

Massarotti EM, Liu NY, Mier J, Atkins MB.

Am J Med. 1992 Jun;92(6):693-7.

PMID:
1605152
30.

Treatment of early Lyme disease.

Massarotti EM, Luger SW, Rahn DW, Messner RP, Wong JB, Johnson RC, Steere AC.

Am J Med. 1992 Apr;92(4):396-403.

PMID:
1313637
31.

Septic arthritis due to Listeria monocytogenes: report and review of the literature.

Massarotti EM, Dinerman H.

J Rheumatol. 1990 Jan;17(1):111-3. Review.

PMID:
2179549

Supplemental Content

Loading ...
Support Center